The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 336:873-875 March 20, 1997 Number 12
NextNext

The 14-3-3 Brain Protein and Transmissible Spongiform Encephalopathy

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Hsich, G.
-PubMed Citation
To the Editor: Hsich et al. (Sept. 26 issue)1 described a new premortem diagnostic test for Creutzfeldt–Jakob disease and the related transmissible spongiform encephalopathies that consists of an immunoassay for the detection of the 14-3-3 brain protein in cerebrospinal fluid. They found that this procedure had a specificity of 99 percent and a sensitivity of 96 percent for the detection of Creutzfeldt–Jakob disease among patients with dementia who had not had a stroke within one month before testing. The authors concluded that their immunoassay "can . . . be widely used to establish the diagnosis of transmissible spongiform encephalopathy in . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.